Cabinet approves continuation of National AIDS Control Programme till 2020

Published On 2019-03-08 04:02 GMT   |   Update On 2019-03-08 04:02 GMT

New Delhi: The Cabinet Committee on Economic Affairs chaired by the Prime Minister has given its approval for continuation of National AIDS Control Programme-IV (NACP-IV) beyond 12th Five Year Plan for a period of three years from April 2017 to March 2020.   The total outlay will be Rs.6434.76 crore.


The program will have the following benefits

  • More than 99% of the population will be kept HIV free.

  • More than 70 lakh of the key population covered annually through a comprehensive HIV prevention programme.

  • Around 15 crore of the vulnerable population (including five crore pregnant women) will be tested for HIV in three years of the project.

  • Two crores 32 lakh units of blood will be collected at NACO’s supported blood banks during the three years of the project.

  • Two crores 82 lakh episodes of sexually transmitted infections will be managed under project during three years of the project.

  • Seventeen lakh of PLHIV will be put on free anti-retroviral treatment by the end of the project period.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News